Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Izpisua Belmonte, J. C.
Text and Data Mining valid from 2020-10-27
Version of Record valid from 2020-10-27
25 September 2020
5 October 2020
27 October 2020
Ethics approval and consent to participate
The authors declare no competing financial and non-financial interests.